The novel nitric oxide (NO)-donating nonsteroidal anti-inflammatory drugs (NO-NSAIDs),
which are safer than their NSAID counterparts, inhibit the growth of colon cancer cells with …

Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NO-NSAIDs), consisting of a
known nonsteroidal anti-inflammatory drug (NSAID) and a nitric oxide (NO)-releasing group …

Nitric-oxide-donating nonsteroidal anti-inflammatory drugs (NO–NSAIDs), which consist of
an NSAID with an NO-donating moiety covalently attached to it, promise to contribute …

Our work aimed at identifying the antitumoral potential of new nitric oxide (NO)-releasing
non-steroidal anti-inflammatory drug (NSAID) derivatives on human prostate and bladder …

Nitric oxide-donating aspirin (NO-aspirin), representing a new concept in the development of
more efficacious nonsteroidal anti-inflammatory drugs, consists of traditional aspirin bearing …

Background Nitric oxide-releasing nonsteroidal antiinflammatory drugs (NO-NSAIDs) are
reported to be safer than NSAIDs because of their lower gastric toxicity. We compared the …

Nitric oxide–releasing nonsteroidal anti-inflammatory drugs (NO-NSAID) are promising
chemoprevention agents; unlike conventional NSAIDs, they seem free of appreciable …

Purpose Previously, we reported in vitro observations suggesting that ibuprofen is an
effective non-prescription non-steroidal anti-inflammatory drug (NSAID) to reduce the …

NO (nitric oxide) biology has provided the impetus for the development of anticancer agents
based on their ability to release NO. NO-NSAIDs (NO-donating non-steroidal anti …

We previously showed that NCX 4040 inhibits in vitro and in vivo tumor growth and induces
apoptosis in human colon cancer cell lines. On the basis of these results, NCX 4040 …